{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:37:19Z","timestamp":1790375839878,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.canlet.2026.218729","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:29:37Z","timestamp":1783924177000},"page":"218729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["HDAC10 suppresses anti-tumour immunity by inhibiting ILF3-CXCL9 axis to block CD8+ T cell infiltration and activation in bladder cancer"],"prefix":"10.1016","volume":"657","author":[{"given":"Juntao","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyou","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengye","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3589-2507","authenticated-orcid":false,"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canlet.2026.218729_bib1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2025 guidelines","volume":"87","author":"van der Heijden","year":"2025","journal-title":"Eur. Urol."},{"issue":"10","key":"10.1016\/j.canlet.2026.218729_bib2","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/s43018-024-00822-0","article-title":"Neoadjuvant gemcitabine-cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial","volume":"5","author":"Li","year":"2024","journal-title":"Nat. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2026.218729_bib3","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/s41588-024-01899-0","article-title":"Five latent factors underlie response to immunotherapy","volume":"56","author":"Usset","year":"2024","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.canlet.2026.218729_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41577-023-00884-8","article-title":"Localization, tissue biology and T cell state - implications for cancer immunotherapy","volume":"23","author":"Schenkel","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218729_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2026.218729_bib6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/bjc.2016.172","article-title":"CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer","volume":"115","author":"Bronger","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218729_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2024.11.011","article-title":"Cytokines in cancer","volume":"43","author":"Kureshi","year":"2025","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.canlet.2026.218729_bib8","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.gt.3302756","article-title":"Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma","volume":"13","author":"Zhang","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2026.218729_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/adma.70627","article-title":"Engineering CRISPR system-based bacterial outer membrane vesicle potentiates T cell immunity for enhanced cancer immunotherapy","author":"Wang","year":"2025","journal-title":"Adv. Mater. (Deerfield Beach, Fla)"},{"key":"10.1016\/j.canlet.2026.218729_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101173","article-title":"Post-translational modifications in drug resistance","volume":"78","author":"Miao","year":"2025","journal-title":"Drug Resist. Updates"},{"issue":"5","key":"10.1016\/j.canlet.2026.218729_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41580-021-00441-y","article-title":"Modulation of cellular processes by histone and non-histone protein acetylation","volume":"23","author":"Shvedunova","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218729_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1158\/2326-6066.CIR-22-0317","article-title":"HDAC3 inhibition promotes antitumor immunity by enhancing CXCL10-Mediated chemotaxis and recruiting of immune cells","volume":"11","author":"Li","year":"2023","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.canlet.2026.218729_bib13","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.7150\/thno.69444","article-title":"HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer","volume":"12","author":"Zhou","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.canlet.2026.218729_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13046-023-02614-3","article-title":"HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1\/PKM2 pathway","volume":"42","author":"Lv","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2026.218729_bib15","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.7150\/ijbs.86719","article-title":"METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway","volume":"20","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.canlet.2026.218729_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor evolution and drug response in patient-derived organoid models of bladder cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell."},{"issue":"13","key":"10.1016\/j.canlet.2026.218729_bib17","article-title":"Patient-derived bladder cancer organoids as a valuable tool for understanding tumor biology and developing personalized treatment","volume":"12","author":"Zhao","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.canlet.2026.218729_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41596-019-0232-9","article-title":"Tumor organoid-T-cell coculture systems","volume":"15","author":"Cattaneo","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2026.218729_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf."},{"issue":"4","key":"10.1016\/j.canlet.2026.218729_bib20","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"issue":"W1","key":"10.1016\/j.canlet.2026.218729_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2026.218729_bib22","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2026.218729_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s40537-023-00844-y","article-title":"BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors","volume":"10","author":"Liu","year":"2023","journal-title":"J. Big Data"},{"issue":"5","key":"10.1016\/j.canlet.2026.218729_bib24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.canlet.2026.218729_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi3664","article-title":"Single-cell joint profiling of multiple epigenetic proteins and gene transcription","volume":"10","author":"Xiong","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.canlet.2026.218729_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-023-00912-8","article-title":"PES1 reduces CD8(+) T cell infiltration and immunotherapy sensitivity via interrupting ILF3-IL15 complex in esophageal squamous cell carcinoma","volume":"30","author":"Ma","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.canlet.2026.218729_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102141","article-title":"Deacetylation-dependent regulation of PARP1 by SIRT2 dictates ubiquitination of PARP1 in oxidative stress-induced vascular injury","volume":"47","author":"Zhang","year":"2021","journal-title":"Redox Biol."},{"issue":"626","key":"10.1016\/j.canlet.2026.218729_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf0992","article-title":"TRIB3 reduces CD8(+) T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer","volume":"14","author":"Shang","year":"2022","journal-title":"Sci. Transl. Med."},{"issue":"D1","key":"10.1016\/j.canlet.2026.218729_bib29","doi-asserted-by":"crossref","first-page":"D719","DOI":"10.1093\/nar\/gkab962","article-title":"UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase\/deubiquitinase-substrate interactions in eukaryotic species","volume":"50","author":"Wang","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.canlet.2026.218729_bib30","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948220","article-title":"Codon bias confers stability to human mRNAs","volume":"20","author":"Hia","year":"2019","journal-title":"EMBO Rep."},{"issue":"1","key":"10.1016\/j.canlet.2026.218729_bib31","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1186\/s12864-020-07291-6","article-title":"RBPsuite: RNA-protein binding sites prediction suite based on deep learning","volume":"21","author":"Pan","year":"2020","journal-title":"BMC Genom."},{"issue":"1","key":"10.1016\/j.canlet.2026.218729_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/advances\/nmx009","article-title":"Butyrate: a double-edged sword for health?","volume":"9","author":"Liu","year":"2018","journal-title":"Adv. Nutr."},{"issue":"5","key":"10.1016\/j.canlet.2026.218729_bib33","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41551-024-01190-x","article-title":"A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice","volume":"8","author":"Cao","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"11","key":"10.1016\/j.canlet.2026.218729_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2024.04.015","article-title":"Circadian tumor infiltration and function of CD8(+) T cells dictate immunotherapy efficacy","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.canlet.2026.218729_bib35","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/nar\/30.5.1114","article-title":"Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain","volume":"30","author":"Tong","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"30","key":"10.1016\/j.canlet.2026.218729_bib36","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102718118","article-title":"EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner","volume":"118","author":"Bugide","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"11","key":"10.1016\/j.canlet.2026.218729_bib37","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.7150\/thno.82535","article-title":"The HDAC10 instructs macrophage M2 program via deacetylation of STAT3 and promotes allergic airway inflammation","volume":"13","author":"Zhong","year":"2023","journal-title":"Theranostics"},{"issue":"765","key":"10.1016\/j.canlet.2026.218729_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.abo4356","article-title":"Degradation of HDAC10 by autophagy promotes IRF3-mediated antiviral innate immune responses","volume":"15","author":"Zhou","year":"2022","journal-title":"Sci. Signal."},{"issue":"73","key":"10.1016\/j.canlet.2026.218729_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abq6509","article-title":"CXCL9 and CXCL10 bring the heat to tumors","volume":"7","author":"Reschke","year":"2022","journal-title":"Sci. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2026.218729_bib40","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","article-title":"Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition","volume":"184","author":"Litchfield","year":"2021","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.canlet.2026.218729_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113014","article-title":"CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity","volume":"42","author":"House","year":"2023","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.canlet.2026.218729_bib42","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","article-title":"Intratumoral activity of the CXCR3 chemokine System is required for the efficacy of Anti-PD-1 therapy","volume":"50","author":"Chow","year":"2019","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.canlet.2026.218729_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218729_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-025-01187-w","article-title":"Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy","author":"Lanitis","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218729_bib45","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1038\/s41467-025-58317-0","article-title":"SIRT7 facilitates endometrial cancer progression by regulating PTEN stability in an estrogen-dependent manner","volume":"16","author":"Hu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218729_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216158","article-title":"HDAC4 mediated LHPP deacetylation enhances its destabilization and promotes the proliferation and metastasis of nasopharyngeal carcinoma","volume":"562","author":"Sun","year":"2023","journal-title":"Cancer Lett."},{"issue":"18","key":"10.1016\/j.canlet.2026.218729_bib47","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1016\/j.cell.2023.07.016","article-title":"A membrane-associated MHC-I inhibitory axis for cancer immune evasion","volume":"186","author":"Chen","year":"2023","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.canlet.2026.218729_bib48","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1158\/0008-5472.CAN-23-3250","article-title":"HDAC inhibition increases CXCL12 secretion to recruit natural killer cells in peripheral T-cell lymphoma","volume":"84","author":"Zhu","year":"2024","journal-title":"Cancer Res."},{"issue":"25","key":"10.1016\/j.canlet.2026.218729_bib49","article-title":"S100A5 attenuates efficiency of Anti-PD-L1\/PD-1 immunotherapy by inhibiting CD8(+) T cell-mediated anti-cancer immunity in bladder carcinoma","volume":"10","author":"Li","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"2","key":"10.1016\/j.canlet.2026.218729_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-013809","article-title":"Targeting RRBP1 reverses immune evasion and enhances immunotherapy efficacy via the CXCL10-CXCR3 axis in bladder cancer","volume":"14","author":"Shen","year":"2026","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2026.218729_bib51","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.trecan.2024.11.003","article-title":"Short-chain fatty acids and cancer","volume":"11","author":"Li","year":"2025","journal-title":"Trends Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2026.218729_bib52","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2249143","article-title":"Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell","volume":"15","author":"Zhu","year":"2023","journal-title":"Gut Microbes"},{"issue":"4","key":"10.1016\/j.canlet.2026.218729_bib53","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","article-title":"Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial","volume":"28","author":"Dizman","year":"2022","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.canlet.2026.218729_bib54","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1038\/s41591-024-03086-4","article-title":"Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial","volume":"30","author":"Ebrahimi","year":"2024","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.canlet.2026.218729_bib55","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.chom.2016.09.001","article-title":"Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome","volume":"20","author":"Maldonado-Gomez","year":"2016","journal-title":"Cell Host Microbe"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526004933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T02:19:07Z","timestamp":1785723547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526004933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":55,"alternative-id":["S0304383526004933"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218729","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HDAC10 suppresses anti-tumour immunity by inhibiting ILF3-CXCL9 axis to block CD8+ T cell infiltration and activation in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218729"}}